RIGEL PHARMACEUTICALS INC Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Rigel Pharmaceuticals Inc quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2019 to Q1 2024.
  • Rigel Pharmaceuticals Inc Operating Lease, Liability, Noncurrent for the quarter ending March 31, 2024 was $100K, a 87.5% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $100K -$702K -87.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $285K -$687K -70.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $466K Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $628K Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $802K Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $972K +$213K +28.1% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $759K -$9.89M -92.9% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $3.31M -$9.62M -74.4% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $5.85M -$9.4M -61.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $8.3M -$9.01M -52.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $10.7M -$8.58M -44.6% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $12.9M -$8.25M -39% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $15.2M -$7.84M -33.9% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $17.3M -$7.65M -30.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $19.2M Dec 31, 2019 10-K 2021-03-02
Q3 2019 $21.2M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $23.1M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $25M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.